![Jason Slingsby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Slingsby
Vorstandsvorsitzender bei
MIP Discovery Ltd. (United Kingdom)
Profil
Jason Slingsby was the founder of ProtAffin Biotechnologie AG, founded in 2005, where the title held was Chief Executive Officer.
Dr. Slingsby is currently Chief Executive Officer at Tozaro Ltd., starting in 2025.
Former jobs include Chief Business Officer at Oxford Biomedica Plc from 2018 to 2023, Principal at InterCel, Inc., Principal at Sosei Co. Ltd., and Member-Supervisory Board at Zytoprotec GmbH.
Education includes a doctorate from Imperial College London and an MBA from London Business School.
Aktive Positionen von Jason Slingsby
| Unternehmen | Position | Beginn |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
 MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Vorstandsvorsitzender | 09.06.2025 |
Ehemalige bekannte Positionen von Jason Slingsby
| Unternehmen | Position | Ende |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01.05.2023 |
Zytoprotec GmbH
 Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for peritoneal dialysis | Direktor/Vorstandsmitglied | - |
Sosei Co. Ltd.
 Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Corporate Officer/Principal | - |
InterCel, Inc.
 InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Corporate Officer/Principal | - |
ProtAffin Biotechnologie AG
 ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Vorstandsvorsitzender | - |
Ausbildung von Jason Slingsby
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Communications |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Commercial Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Health Technology |
Zytoprotec GmbH
Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for peritoneal dialysis | Health Technology |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Health Technology |
